You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
生物股份(600201.SH)2019年度淨利潤降70.7%至2.21億元 擬10派0.6元
格隆匯 03-29 15:31

格隆匯3月29日丨生物股份(600201.SH)披露2019年年度報告,實現營業收入11.27億元,同比減少40.59%;歸屬於上市公司股東的淨利潤2.21億元,同比減少70.70%;歸屬於上市公司股東的扣除非經常性損益的淨利潤2.15億元,同比下降70.64%;基本每股收益0.20元,擬每10股派送現金紅利0.60元(含税)。

公司主要從事獸用生物製品的研發、生產與銷售,產品種類涵蓋豬、禽、反芻和寵物類四大系列100餘種動物疫苗。公司擁有口蹄疫和高致病性禽流感兩大強制免疫疫苗農業部定點生產資質,工藝技術和產品質量保持國內領先水平。

同時,依託動物生物安全三級實驗室(ABSL-3)、獸用疫苗國家工程實驗室、農業部反芻動物生物製品重點實驗室三個國家級實驗室研發平台,憑藉智能製造對疫苗生產全生命週期控制,配套專業完善的技術服務和銷售渠道,進而為客户提供動物疫病防控整體解決方案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account